Applied DNA Sciences, Inc.
APDN
$0.811
$0.0111.38%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 1.20M | 813.10K | 797.50K | 929.60K | 891.20K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.20M | 813.10K | 797.50K | 929.60K | 891.20K |
| Cost of Revenue | 512.50K | 568.20K | 552.30K | 634.00K | 660.10K |
| Gross Profit | 684.10K | 244.90K | 245.20K | 295.70K | 231.10K |
| SG&A Expenses | 2.63M | 2.68M | 2.68M | 3.00M | 3.08M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 4.16M | 4.08M | 4.14M | 4.55M | 4.68M |
| Operating Income | -2.96M | -3.27M | -3.35M | -3.62M | -3.79M |
| Income Before Tax | -2.67M | -3.31M | 1.85M | -4.49M | -1.13M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.67M | -3.31M | 1.85M | -4.49M | -1.13M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 29.30K | 17.00K | 30.30K | 23.30K | 25.20K |
| Net Income | -2.64M | -3.30M | 1.88M | -4.47M | -1.11M |
| EBIT | -2.96M | -3.27M | -3.35M | -3.62M | -3.79M |
| EBITDA | -2.91M | -3.19M | -3.21M | -3.43M | -3.49M |
| EPS Basic | -27.84 | -16.00 | 23.41 | -265.45 | -86.51 |
| Normalized Basic EPS | -2.60 | -9.97 | 14.78 | -159.84 | -49.82 |
| EPS Diluted | -27.84 | -16.00 | 23.41 | -265.45 | -86.51 |
| Normalized Diluted EPS | -2.60 | -9.97 | 14.78 | -159.84 | -49.82 |
| Average Basic Shares Outstanding | 630.40K | 206.00K | 80.30K | 17.40K | 13.70K |
| Average Diluted Shares Outstanding | 630.40K | 206.00K | 80.30K | 17.40K | 13.70K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |